Breast Cancer

Recruiting

Comparing surgical and nonsurgical chronic lymphedema treatment after breast cancer therapy

The purpose of this study is to determine whether lymphatic surgery provides better quality of life compared to only conservative therapy for patients with breast cancer-related lymphedema.

Status

Recruiting

Closed for Recruitment

A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Primary Breast Cancer

This two-arm, randomized, open-label, multicenter study will evaluate the efficacy and safety of Kadcyla (trastuzumab emtansine, also known as T-DM1) in combination with Perjeta (pertuzumab) versus Herceptin (trastuzumab) in combination with Perjeta and a taxane as adjuvant therapy in patients with HER2-positive primary invasive breast cancer.

Status

Closed for Recruitment

Subscribe to Breast Cancer